Prior genomic studies have reported recurrent alterations in key molecular pathways in ccRCC-R, including chromatin remodeling genes, DNA damage repair (DDR) pathways, and components of oncogenic signaling cascades such as PI3K/AKT/mTOR and MAPK [7,8]. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.